II
IIL.GSE INTRAVENOUS INFUSIONS LIMITED
0.5600 GHS
Close of Oct 28, 2026
0.0500
0.8600
- Market cap
- -
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is IIL.GSE undervalued?
Graham numberThe Graham number of INTRAVENOUS INFUSIONS LIMITED cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
INTRAVENOUS INFUSIONS LIMITED fundamental analysis
No fundamental analysis for INTRAVENOUS INFUSIONS LIMITED yet.
INTRAVENOUS INFUSIONS LIMITED stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
Financial statements of INTRAVENOUS INFUSIONS LIMITED are not available yet.
INTRAVENOUS INFUSIONS LIMITED dividends
INTRAVENOUS INFUSIONS LIMITED has not paid dividends in the last 1 fiscal years.
Who owns INTRAVENOUS INFUSIONS LIMITED
Ownership data of INTRAVENOUS INFUSIONS LIMITED is not available yet.
INTRAVENOUS INFUSIONS LIMITED company profile
- Company name
- INTRAVENOUS INFUSIONS LIMITED
- Ticker
- IIL.GSE
- ISIN
- GH0000001258
- Exchange
- Ghana Stock Exchange
- Sector
- -
- Industry
- -
- Address
- Website
- -